Show simple item record

dc.contributor.authorChad W. Euler
dc.contributor.authorBarbara Juncosa
dc.contributor.authorPatricia A. Ryan
dc.contributor.authorDouglas R. Deutsch
dc.contributor.authorW. Michael McShan
dc.contributor.authorVincent A. Fischetti
dc.date.accessioned2017-03-04T01:59:51Z
dc.date.available2017-03-04T01:59:51Z
dc.date.issued2016-01-12
dc.identifier.citationEuler CW, Juncosa B, Ryan PA, Deutsch DR, McShan WM, Fischetti VA (2016) Targeted Curing of All Lysogenic Bacteriophage from Streptococcus pyogenes Using a Novel Counter-selection Technique. PLoS ONE 11(1): e0146408. doi:10.1371/journal.pone.0146408en_US
dc.identifier.urihttps://hdl.handle.net/11244/49231
dc.descriptionWe thank the members of the Laboratory of Microbial Pathogenesis and Immunology, especially Annette Nelkenbaum and Ben Winer for their technical assistance. We also thank Estee Colleen Cervantes and Sutapa Banerjee from Hunter College for their technical contribution to this project. We are grateful to Joseph Ferretti for S. pyogenes strain SF370.en_US
dc.descriptionen_US
dc.description.abstractStreptococcus pyogenes is a human commensal and a bacterial pathogen responsible for a wide variety of human diseases differing in symptoms, severity, and tissue tropism. The completed genome sequences of >37 strains of S. pyogenes, representing diverse disease-causing serotypes, have been published. The greatest genetic variation among these strains is attributed to numerous integrated prophage and prophage-like elements, encoding several virulence factors. A comparison of isogenic strains, differing in prophage content, would reveal the effects of these elements on streptococcal pathogenesis. However, curing strains of prophage is often difficult and sometimes unattainable. We have applied a novel counter-selection approach to identify rare S. pyogenes mutants spontaneously cured of select prophage. To accomplish this, we first inserted a two-gene cassette containing a gene for kanamycin resistance (KanR) and the rpsL wild-type gene, responsible for dominant streptomycin sensitivity (SmS), into a targeted prophage on the chromosome of a streptomycin resistant (SmR) mutant of S. pyogenes strain SF370. We then applied antibiotic counter-selection for the re-establishment of the KanS/SmR phenotype to select for isolates cured of targeted prophage. This methodology allowed for the precise selection of spontaneous phage loss and restoration of the natural phage attB attachment sites for all four prophage-like elements in this S. pyogenes chromosome. Overall, 15 mutants were constructed that encompassed every permutation of phage knockout as well as a mutant strain, named CEM1ΔΦ, completely cured of all bacteriophage elements (a ~10% loss of the genome); the only reported S. pyogenes strain free of prophage-like elements. We compared CEM1ΔΦ to the WT strain by analyzing differences in secreted DNase activity, as well as lytic and lysogenic potential. These mutant strains should allow for the direct examination of bacteriophage relationships within S. pyogenes and further elucidate how the presence of prophage may affect overall streptococcal survival, pathogenicity, and evolution.en_US
dc.language.isoen_USen_US
dc.publisherPLos One
dc.relation.ispartofseriesPLoS ONE 11(1): e0146408
dc.relation.urihttp://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0146408
dc.rightsAttribution 3.0 United States
dc.rights.urihttps://creativecommons.org/licenses/by/3.0/us/
dc.subjectBacteriophages,Streptococcus pyogenes,Deoxyribonucleases,Viral genomics,Chromosomes,Polymerase chain reaction,Streptomycin,Bacterial pathogensen_US
dc.titleTargeted Curing of All Lysogenic Bacteriophage from Streptococcus pyogenes Using a Novel Counter-selection Techniqueen_US
dc.typeResearch Articleen_US
dc.description.peerreviewYesen_US
dc.description.peerreviewnoteshttp://www.plosone.org/static/editorial#peeren_US
dc.identifier.doi10.1371/journal.pone.0146408en_US
dc.rights.requestablefalseen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record


Attribution 3.0 United States
Except where otherwise noted, this item's license is described as Attribution 3.0 United States